CYP3A5 *3/*3 subjects were related to higher risk of myalgia and muscle damage compared to *1/*3 subjects [33] and to increased response to atorvastatin compared to *1/*1 + *1/*3 subjects [34]. The gene discussed is CYP3A5; the disease is Myalgia.